[HTML] nature.comFull View

[HTML][HTML] Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations

NC Cullen, A Leuzy, S Janelidze, S Palmqvist… - Nature …, 2021 - nature.com
Plasma biomarkers of amyloid, tau, and neurodegeneration (ATN) need to be characterized
in cognitively unimpaired (CU) elderly individuals. We therefore tested if plasma …
被引用次数：163 相关文章

Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations.

NC Cullen, A Leuzy, S Janelidze, S Palmqvist… - Nature …, 2021 - europepmc.org
Plasma biomarkers of amyloid, tau, and neurodegeneration (ATN) need to be characterized
in cognitively unimpaired (CU) elderly individuals. We therefore tested if plasma …

Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations

NC Cullen, A Leuzy, S Janelidze, S Palmqvist… - Nature …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Plasma biomarkers of amyloid, tau, and
neurodegeneration (ATN) need to be characterized in cognitively unimpaired (CU) elderly …

Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations.

NC Cullen, A Leuzy, S Janelidze… - Nature …, 2021 - search.ebscohost.com
Plasma biomarkers of amyloid, tau, and neurodegeneration (ATN) need to be characterized
in cognitively unimpaired (CU) elderly individuals. We therefore tested if plasma …

Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations

NC Cullen, A Leuzy, S Janelidze, S Palmqvist… - Nature …, 2021 - ideas.repec.org
Plasma biomarkers of amyloid, tau, and neurodegeneration (ATN) need to be characterized
in cognitively unimpaired (CU) elderly individuals. We therefore tested if plasma …

Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations

NC Cullen, A Leuzy, S Janelidze… - Nature …, 2021 - portal.research.lu.se
Plasma biomarkers of amyloid, tau, and neurodegeneration (ATN) need to be characterized
in cognitively unimpaired (CU) elderly individuals. We therefore tested if plasma …

Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations

NC Cullen, A Leuzy, S Janelidze… - Nature …, 2021 - pubmed.ncbi.nlm.nih.gov
Plasma biomarkers of amyloid, tau, and neurodegeneration (ATN) need to be characterized
in cognitively unimpaired (CU) elderly individuals. We therefore tested if plasma …

Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations

NC Cullen, A Leuzy, S Janelidze… - Nature …, 2021 - econpapers.repec.org
Plasma biomarkers of amyloid, tau, and neurodegeneration (ATN) need to be characterized
in cognitively unimpaired (CU) elderly individuals. We therefore tested if plasma …

Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations

NC Cullen, A Leuzy, S Janelidze, S Palmqvist… - Nature …, 2021 - lup.lub.lu.se
Plasma biomarkers of amyloid, tau, and neurodegeneration (ATN) need to be characterized
in cognitively unimpaired (CU) elderly individuals. We therefore tested if plasma …

Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations

NC Cullen, A Leuzy, S Janelidze… - Nature …, 2021 - ui.adsabs.harvard.edu
Plasma biomarkers of amyloid, tau, and neurodegeneration (ATN) need to be characterized
in cognitively unimpaired (CU) elderly individuals. We therefore tested if plasma …